NCT06376682 2025-09-22
EPIBONE
Precision IO Group
Phase NA Completed
Clinical Trials
14 trialsNCT05847868 2025-07-03
KRIOS
Estas Tıbbi Mamülleri Medikal
Phase NA Completed
NCT00321464 2022-11-08
A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
Amgen
Phase 3 Completed
NCT01345019 2022-11-08
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Amgen
Phase 3 Completed
NCT01646437 2021-09-16
TIPS-3
Population Health Research Institute
Phase 3 Completed
NCT03912168 2020-03-19
Question Prompt List for Orthopaedic Conditions
Stanford University
Phase NA Completed
NCT03076138 2019-05-07
Gene-activated Bone Substitute for Maxillofacial Bone Regeneration
Histograft Co., Ltd.
Phase NA Completed
NCT00639210 2019-02-26
BREX
Finnish Breast Cancer Group
Phase 3 Completed
NCT00321620 2018-08-29
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
Amgen
Phase 3 Completed
NCT03192683 2017-06-20
Modified "Providence" Pedi Cast-Sling vs.Cast and Sling
Lifespan
Phase NA Completed
NCT01920568 2017-01-16
A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors
GlaxoSmithKline
Phase 3 Completed
NCT00129142 2013-11-15
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
GTx
Phase 3 Completed
NCT00766532 2012-09-14
Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?
University of Wisconsin, Madison
Phase 4 Completed
NCT00252408 2009-09-04
Danish Osteoporosis Prevention Study
University of Aarhus
Phase 4 Completed